Skip to content

Tracking the Global Burden of Vector-Borne Disease

The burden of vector-borne diseases (VBDs) is one of public health’s most pressing challenges. VBDs are caused by pathogens such as arboviruses (arthropod-borne virus), bacteria, and parasites that are transmitted to humans and animals through the bites of infected arthropods including mosquitoes, ticks, sandflies, and fleas, among others. According to the World Health Organization (WHO) , “vector-borne diseases account for more than 17% of all infectious diseases, causing more than 700,000 deaths annually worldwide”.

Beyond these broad statistics, attempts to quantify the global burden of VBDs is extremely challenging – for a number of reasons. At the highest level, even “burden” has an underlying complexity in public health terms: burden may refer to the number of cases of a given disease as well as the number of deaths.

Burden can also represent Disability-adjusted Life Years (DALYs), a measure that accounts for the long-term effects of disability among the afflicted, as well as the economic impact of disease from regions and countries all the way down to households and individuals. These economic impacts can be further scrutinized as reduced productivity among the populace, increased healthcare costs, and negative impacts on tourism; all of which can directly affect the GDP and economic growth of local and regional economies. And that’s just the beginning.

Valent BioSciences Team Brings Forth Novel Mode of Action Targeting Pyrethroid-Resistant Mosquitoes

Ten-Year Development Project Results in potential for First Mosquito Adulticide Based on Fermentation Technology An Experimental Use Permit (EUP) application has been submitted to US …

New MoA Success Drives Provocative Research with Broad Implications

Impact of ivermectin in onchocerciasis control could be just the beginning The iconic story behind onchocerciasis elimination efforts offers lessons that extend well into the …

It All Started with a Gift

Merck’s commitment to donate ivermectin for onchocerciasis control in the late 80s was only the beginning of the challenge to deliver the intervention to those …

Silencing River Blindness – a Legendary Story of Public Health Triumph

As the world marshals its collective resources in the fight against COVID-19, an often forgotten major Public Health accomplishment achieved through an intense global Public-Private …